Trials / Conditions / Eosinophilic Gastritis

Eosinophilic Gastritis

11 registered clinical trials studyying Eosinophilic Gastritis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study of Gastric Motility in Eosinophilic Gastritis NCT05229432	Children's Hospital Medical Center, Cincinnati	—
Terminated	Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON NCT05251909	AstraZeneca	Phase 3
Withdrawn	A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis NCT05152563	Allakos Inc.	Phase 3
Completed	Dupilumab in Eosinophilic Gastritis NCT03678545	Children's Hospital Medical Center, Cincinnati	Phase 2
Completed	An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred NCT04620811	Allakos Inc.	Phase 3
Completed	A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosi NCT04322604	Allakos Inc.	Phase 3
Completed	An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis NCT03664960	Allakos Inc.	Phase 2
Completed	A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis NCT03496571	Allakos Inc.	Phase 2
Completed	Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort NCT02897271	Children's Hospital Medical Center, Cincinnati	—
Recruiting	OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118	Children's Hospital Medical Center, Cincinnati	—
Withdrawn	Eosinophilic Gastrointestinal Disorders Patient Registry NCT01779154	Arkansas Children's Hospital Research Institute	—